Literature DB >> 9438675

Differential effects of chlordiazepoxide on aggressive behavior in male mice: the influence of social factors.

P F Ferrari1, S Parmigiani, R J Rodgers, P Palanza.   

Abstract

The present study examined the influence of prior social experience on the effects of chlordiazepoxide (CDP; 5.0, 10.0 and 20.0 mg/kg) on intrasexual aggression in male mice. Prior to drug testing, animals were either individually housed or screened in dyadic encounters in a neutral cage. This novel method yielded four experimental groups comprising animals with different social experiences and different aggressive/defensive characteristics: 1) individually-housed males (I): 2) aggressive males (A); 3) counter-attacking males (C), which actively responded to but did not initiate attack; and 4) defeated males (D). Twenty-four hours after screening, animals were treated with CDP and subjected to a resident-intruder test with untreated intruders. Results indicated that the lowest dose of CDP (5 mg/kg) increased aggressive behaviour but only in A males. At higher doses (10-20 mg/kg), CDP reduced attacks towards intruders in A, C and I, but not D, males. In A and C males, the antiaggressive action of CDP was associated with a prosocial effect (increased social investigation), whereas in I males, reduced aggression was associated with an increase in fear-related behaviours. As these differential effects of CDP on intermale aggression cannot be fully explained by differences in behavioural baselines, present data highlight the importance of experiential background as a powerful variable in determining behavioural responses to benzodiazepines. Present findings therefore suggest that an understanding of drug effects on social behaviour demands consideration of biological variability in phenotype.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9438675     DOI: 10.1007/s002130050448

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  8 in total

1.  GABA(A) receptors in the dorsal raphé nucleus of mice: escalation of aggression after alcohol consumption.

Authors:  Aki Takahashi; Carolyn Kwa; Joseph F Debold; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2010-06-30       Impact factor: 4.530

2.  α2-containing GABA(A) receptors: a requirement for midazolam-escalated aggression and social approach in mice.

Authors:  Emily L Newman; Kiersten S Smith; Aki Takahashi; Adam Chu; Lara S Hwa; Yang Chen; Joseph F DeBold; Uwe Rudolph; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2015-09-17       Impact factor: 4.530

3.  Escalated aggression as a reward: corticosterone and GABA(A) receptor positive modulators in mice.

Authors:  Eric W Fish; Joseph F DeBold; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2005-08-13       Impact factor: 4.530

Review 4.  Behavioral and pharmacogenetics of aggressive behavior.

Authors:  Aki Takahashi; Isabel M Quadros; Rosa M M de Almeida; Klaus A Miczek
Journal:  Curr Top Behav Neurosci       Date:  2012

Review 5.  Neurogenetics of aggressive behavior: studies in rodents.

Authors:  Aki Takahashi; Klaus A Miczek
Journal:  Curr Top Behav Neurosci       Date:  2014

Review 6.  The role of hormones and hormonal treatments in premenstrual syndrome.

Authors:  Torbjörn Bäckström; Lotta Andreen; Vita Birzniece; Inger Björn; Inga-Maj Johansson; Maud Nordenstam-Haghjo; Sigrid Nyberg; Inger Sundström-Poromaa; Göran Wahlström; Mingde Wang; Di Zhu
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

7.  Benzodiazepines and heightened aggressive behavior in rats: reduction by GABA(A)/alpha(1) receptor antagonists.

Authors:  Shannon L Gourley; Joseph F Debold; Wenyuan Yin; James Cook; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2004-08-17       Impact factor: 4.530

8.  Influence of sex and genetic background on anxiety-related and stress-induced behaviour of prodynorphin-deficient mice.

Authors:  Iris Kastenberger; Christian Lutsch; Herbert Herzog; Christoph Schwarzer
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.